FL

Felix Lansing

Chief Technology Officer

Seamless Therapeutics

Dresden, Saxony


Contact Information

Email
Unlock
LinkedIn

Company Information

Company
Seamless Therapeutics
Industry
biotechnology
Employees
39.0
Seniority
C suite
Annual Revenue
1500000.0
Total Funding
12500000.0
Latest Funding
Seed

Technologies

Outlook WordPress.org Google Font API Mobile Friendly Remote

Keywords

gene editing programmable recombinases genome engineering genetic disease therapy dna modifications disease-modifying therapies large dna deletions precise dna insertions human genome correction recombinase technology therapeutic applications molecular biology solutions crispr alternatives genomic precision genetic therapies development biopharmaceutical innovations clinical research scientific collaboration r&d pipelines biotechnology advancement patient outcomes improvement gene therapies regenative biology innovative therapeutics genetic engineering medical biotechnology custom genetic solutions enhanced gene therapy genetic modification translational medicine life science innovation clinical trial support public health solutions therapeutic gene delivery genome editing platforms precision medicine genetic disorder treatments next-gen therapeutics pharmaceutical development genetic research healthcare impact biotechnology leadership disease treatment strategies scientific excellence team collaboration cutting-edge science genetic engineering techniques bioethics in medicine personalized gene therapy drug development

Get Full Contact Details

Subscribe to reveal email addresses and export contacts.

View Plans